Accentia Biopharmaceuticals granted exclusivity extension to Dec. 4

By Lisa Kerner

Charlotte, N.C., Nov. 20 - Accentia Biopharmaceuticals, Inc. was granted approval to extend its exclusive periods for filing a plan of reorganization and soliciting votes on the plan, according to a Friday filing with the U.S. Bankruptcy Court for the Middle District of Florida.

The exclusive plan-filing period was extended to Dec. 4 from Nov. 20, and the solicitation period was extended to Jan. 31 if the plan is filed by Dec. 4.

Accentia, a biopharmaceutical company based in Tampa, Fla., filed for bankruptcy on Nov. 10, 2008. Its Chapter 11 case number is 08-17795.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.